Tortoise Investment Management, LLC Abb Vie Inc. Transaction History

Tortoise Investment Management, LLC

$905 Million
Q3 2024

A detailed history of Tortoise Investment Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tortoise Investment Management, LLC holds 1,338 shares of ABBV stock, worth $240,840. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,338

Previous 1,105 21.09%

Holding current value

$240,840

Previous $189,000 39.68%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $38,174 - $46,443	233 Added 21.09%	1,338 $264,000
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $15,324 - $17,895	99 Added 9.84%	1,105 $189,000
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $3,995 - $4,552	-25 Reduced 2.42%	1,006 $183,000
Q4 2023 Feb 29, 2024	BUY	$137.6 - $154.97 $4,128 - $4,649	30 Added 3.0%	1,031 $159,000
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $20,640 - $23,245	-150 Reduced 13.03%	1,001 $155,000
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $1,202 - $1,391	-9 Reduced 0.78%	1,151 $171,000
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $2,517 - $3,133	-19 Reduced 1.61%	1,160 $156,000
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $6,507 - $7,494	-45 Reduced 3.68%	1,179 $187,000
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $12,032 - $14,430	87 Added 7.65%	1,224 $197,000
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $61,468 - $70,499	458 Added 67.45%	1,137 $153,000
Q2 2022 Aug 03, 2022	BUY	$137.62 - $174.96 $8,945 - $11,372	65 Added 10.59%	679 $104,000
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $21,908 - $27,182	166 Added 37.05%	614 $100,000
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $3,617 - $4,106	-34 Reduced 7.05%	448 $48,000
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $13,677 - $15,237	130 Added 36.93%	482 $54,000
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $2,864 - $3,153	28 Added 8.64%	352 $38,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $5,553 - $7,498	69 Added 27.06%	324 $35,000
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $687 - $806	-8 Reduced 3.04%	255 $22,000
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $14,087 - $18,850	-192 Reduced 42.2%	263 $26,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $4,255 - $5,324	-59 Reduced 11.48%	455 $40,000
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $6,298 - $7,572	-100 Reduced 16.29%	514 $39,000
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $18,987 - $24,270	-289 Reduced 32.0%	614 $45,000
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $15,428 - $18,158	200 Added 28.45%	903 $73,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $15,569 - $19,202	200 Added 39.76%	703 $65,000
Q3 2018 Nov 20, 2018	SELL	$88.91 - $98.84 $14,936 - $16,605	-168 Reduced 25.04%	503 $48,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $22,174 - $29,693	-241 Reduced 26.43%	671 $64,000
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $52,750 - $57,845	589 Added 182.35%	912 $88,000
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $22,561 - $28,818	323	323 $29,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.

Account

Tortoise Investment Management, LLC Abb Vie Inc. Transaction History